OVAREST
Dead / Cancelled — Cancelled — Section 8 (as of 17 May 2024)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86400353
- Registration number
- 5330032
- Mark type
- Stylized text
- Filed
- 19 Sept 2014
- Published for opposition
- 10 Feb 2015
- Registered
- 07 Nov 2017
- Attorney of record
- David J. Dykeman
Goods and services
- Class 005 — Pharmaceuticals: Synthetic peptides for the treatment of endometriosis
Owner
- Enteris BioPharma Inc., Boonton, NJ, US
- Enteris BioPharma Inc., Boonton, NJ, US
- Enteris BioPharma Inc., Boonton, NJ, US
Prosecution history
- 17 May 2024 — CANCELLED SEC. 8 (6-YR)
- 07 Nov 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 07 Nov 2017 — REGISTERED-PRINCIPAL REGISTER
- 05 Oct 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 04 Oct 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 Oct 2017 — STATEMENT OF USE PROCESSING COMPLETE
- 25 Sept 2017 — USE AMENDMENT FILED
- 25 Sept 2017 — TEAS STATEMENT OF USE RECEIVED
- 21 Jun 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Jun 2017 — SOU EXTENSION 4 GRANTED
- 07 Apr 2017 — SOU EXTENSION 4 FILED
- 16 Jun 2017 — NOTICE OF REVIVAL - E-MAILED
- 16 Jun 2017 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 16 Jun 2017 — PETITION TO REVIVE-GRANTED
- 16 Jun 2017 — TEAS PETITION TO REVIVE RECEIVED